Pharmaceutical Supply Chains - Medicines Shortages
In: Lecture Notes in Logistics Ser.
Intro -- Support -- Foreword -- Preface -- Contents -- Contributors -- Acknowledgements -- Talkers, Lecturers and Reviewers -- The European Medicines Shortages Research Network and Its Mission to Strategically Debug Disrupted Pharmaceutical Supply Chains -- 1 Introduction -- 2 European Medicines Shortages Research Network Under the COST Roof -- 3 A History and Review of Medicines Shortages -- 4 Identification of the Stakeholders -- 5 Defining the Term "Medicines Shortages" -- 6 First and Analytical Milestone of the Network's Mission: Mapping Causations of Shortages -- 7 Second and Creative-Innovative Milestone of the Network's Mission: A Methodological Approach to Improve the Medicines Shortages Situation -- 8 Conclusions -- References -- Design and Planning of Sustainable Vaccine Supply Chain -- 1 Introduction -- 2 Literature Review -- 2.1 Sustainable Supply Chain Management -- 2.2 Supply Networks -- 3 The Vaccine Supply Chain -- 4 Problem Definition and Model Characterization -- 4.1 Mathematical Formulation -- 4.2 Objective Functions -- 4.3 Economic Objective Function -- 4.4 Environmental Objective Function -- 4.5 Social Objective Function -- 4.6 Constraints -- 5 Case Study Description -- 6 Results -- 6.1 Single Objective Optimization -- 6.2 Multi-objective Approach -- 7 Conclusions -- Appendix 1. MILP Formulation Adapted from Mota et al. (2015) -- References -- Drug Shortages and Their Impact on Patients and Health Care Systems-How Can Systemic and Organizational Frameworks Help to Prevent or Mitigate Them? -- 1 Introduction -- 2 Impact of Drug Shortages on Patients and Health Care Systems -- 2.1 Impacts on Patients and of Medical Nature -- 2.2 Impacts on Health Care Systems and of Financial Nature -- 3 Systemic and Organizational Frameworks Which Could Counteract DS and Counterweigh Impacts of DS.